LATEST ACADEMIC YEAR UPDATE • CHAMBERLAIN UNIVERSITY / ATI /
HESI
NR 565 ADVANCED PHARMACOLOGY
FINAL & MIDTERM EXAM TEST BANK
100 Verified Exam Questions with Correct Answers & Detailed Clinical Rationales
✓ 100% VERIFIED CORRECT ANSWERS ✓ COMPLETE STEP-BY-STEP RATIONALES
✓ ALREADY GRADED A+ (GUARANTEED PASS)
SECTION 1: PHARMACOKINETICS, PHARMACODYNAMICS, PGX & QUESTIONS 1 – 5
PRESCRIPTIVE AUTHORITY OF 100
1. A nurse practitioner is prescribing Warfarin to a patient who was recently started on Fluconazole for
candidiasis. Which pharmacokinetic interaction is expected, and what adjustment is required?
A. Fluconazole induces CYP2C9, decreasing Warfarin levels and requiring a dose increase.
B. Fluconazole inhibits CYP2C9, increasing S-warfarin levels and bleeding risk; reduce Warfarin dose and monitor INR.
C. Fluconazole blocks intestinal P-glycoprotein efflux, preventing Warfarin absorption.
D. Fluconazole competes for renal tubular secretion, prolonging prothrombin time.
CORRECT ANSWER: B. Rationale: S-warfarin (the more potent enantiomer) is metabolized primarily by hepatic CYP2C9.
Fluconazole, Amiodarone, and Trimethoprim-Sulfamethoxazole are potent CYP2C9 inhibitors that significantly elevate INR and
bleeding risk.
2. Prior to initiating Carbamazepine in a patient of Southeast Asian descent for trigeminal neuralgia, FDA
guidelines mandate pharmacogenomic screening for which allele to prevent Stevens-Johnson Syndrome (SJS)
and Toxic Epidermal Necrolysis (TEN)?
A. HLA-B*5701 B. CYP2C19*2 C. HLA-B*1502 D. TPMT*3A
CORRECT ANSWER: C. Rationale: The HLA-B*1502 allele strongly predisposes patients of Asian ancestry to fatal
Carbamazepine- and Phenytoin-induced SJS/TEN. (HLA-B*5701 screens for Abacavir hypersensitivity; TPMT screens for
Azathioprine myelosuppression).
3. A postoperative patient receives oral Codeine for pain control but reports zero analgesic relief despite full
adherence. Genetic testing reveals the patient is a CYP2D6 ultrarapid or poor metabolizer. Which finding explains
a lack of analgesia?
A. Poor CYP2D6 metabolizers cannot O-demethylate Codeine into its active metabolite, Morphine.
B. Ultrarapid CYP2D6 metabolizers clear Codeine via renal filtration before receptor binding.
C. Codeine requires CYP3A4 activation into hydromorphone.
D. Poor CYP2D6 metabolizers experience rapid mu-opioid receptor desensitization.
CORRECT ANSWER: A. Rationale: Codeine is an inactive prodrug that requires hepatic CYP2D6 conversion into Morphine
for analgesia. Poor metabolizers get zero pain relief, whereas ultrarapid metabolizers generate toxic morphine levels
(contraindicated in children and breastfeeding mothers).
4. Under DEA federal controlled substance regulations, which prescribing rule applies to Schedule II controlled
substances (e.g., Oxycodone, Methylphenidate, Fentanyl)?
A. Up to 5 refills are permitted within a 6-month window.
B. No refills are permitted; a new prescription is required for each dispensing, though multiple dated sequential prescriptions up
to a 90-day supply may be issued.
C. Schedule II prescriptions may be telephoned to the pharmacy for routine maintenance.
D. Nurse practitioners are federally prohibited from prescribing Schedule II drugs in all 50 states.
CORRECT ANSWER: B. Rationale: Schedule II drugs have high abuse potential and zero refills allowed. Providers may
issue up to three sequential 30-day prescriptions with explicit "Do not fill until [Date]" instructions if allowed by state law.
5. An elderly patient presents with hypoalbuminemia (serum albumin 2.1 g/dL) due to malnutrition and takes
Phenytoin (90% protein-bound). Why is a standard total serum Phenytoin level misleading in this patient?
NR 565 Advanced Pharmacology Final & Midterm Exam Test Bank (2026/2027) Page 1 of 14
, SECTION 1 (CONT.): PHARMACODYNAMICS, BEERS CRITERIA & SPECIAL QUESTIONS 6 – 13 OF
POPULATIONS 100
6. A patient who is physically dependent on high-dose full mu-opioid agonists (Heroin/Fentanyl) is inadvertently
given Buprenorphine while full opioids still occupy their receptors. Within 15 minutes, the patient develops severe
abdominal cramps, diaphoresis, and agitation. What pharmacodynamic property of Buprenorphine explains this?
A. Pure competitive mu-opioid antagonism with low receptor affinity.
B. Partial mu-opioid agonist with very high receptor affinity, displacing full agonists and precipitating acute withdrawal.
C. Inverse agonism at GABA-A chloride channels.
D. Non-competitive blockade of N-methyl-D-aspartate (NMDA) receptors.
CORRECT ANSWER: B. Rationale: Buprenorphine is a partial mu-opioid agonist with extremely high binding affinity.
Administering it before a patient is in mild-to-moderate withdrawal displaces full agonists and drops intrinsic receptor
activation, causing precipitated withdrawal.
7. A 54-year-old patient taking Simvastatin 40 mg daily begins drinking 16 oz of grapefruit juice every morning.
Two weeks later, the patient presents with severe diffuse myalgias and dark brown urine. What is the mechanism?
A. Grapefruit furanocoumarins inhibit intestinal CYP3A4, drastically reducing first-pass metabolism and causing statin-induced
rhabdomyolysis.
B. Grapefruit juice induces hepatic CYP2C9, generating myotoxic statin metabolites.
C. Vitamin C acidifies the urine and precipitates Simvastatin crystals in the renal tubules.
D. Grapefruit juice blocks hepatic OATP1B1 uptake, lowering plasma statin concentrations.
CORRECT ANSWER: A. Rationale: Simvastatin, Lovastatin, and Atorvastatin undergo extensive intestinal and hepatic
CYP3A4 metabolism. Grapefruit juice irreversibly inhibits intestinal CYP3A4, increasing systemic statin exposure up to 10-fold
and triggering rhabdomyolysis. (Pravastatin and Rosuvastatin are non-CYP3A4 alternatives).
8. According to the American Geriatrics Society (AGS) Beers Criteria, why are first-generation antihistamines
(Diphenhydramine) and tricyclic antidepressants (Amitriptyline) strongly avoided in older adults?
A. They induce severe hyperkalemia and Type 4 renal tubular acidosis.
B. Their potent antimuscarinic (anticholinergic) activity precipitates acute delirium, falls, cognitive decline, blurred vision, and
urinary retention.
C. They cause irreversible pulmonary fibrosis within 30 days.
D. They selectively stimulate beta-1 adrenergic receptors.
CORRECT ANSWER: B. Rationale: Older adults have reduced central cholinergic reserve. Strong anticholinergic drugs cross
the blood-brain barrier and block M1–M3 receptors, significantly increasing the risk of delirium, incident dementia, falls,
xerostomia, constipation, and acute urinary retention in BPH.
9. A 28-year-old pregnant woman at 10 weeks gestation presents with newly diagnosed hypertension (BP 158/98
mmHg). Which antihypertensive medication is strictly contraindicated due to fetal renal dysplasia,
oligohydramnios, and Potter sequence?
A. Labetalol B. Extended-release Nifedipine C. Lisinopril D. Alpha-Methyldopa
CORRECT ANSWER: C. Rationale: ACE inhibitors (Lisinopril), ARBs (Losartan), and Direct Renin Inhibitors (Aliskiren) are
teratogenic and carry an FDA Black Box Warning in pregnancy. Safe antihypertensives in pregnancy are Labetalol, Nifedipine,
Methyldopa, and Hydralazine.
10. A drug has an elimination half-life (t1/2) of 12 hours and is administered at a fixed maintenance dose every 12
hours without a loading dose. Approximately how long will it take to reach steady-state plasma concentration (94–
97%)?
A. 12 hours (1 half-life) B. 24 hours (2 half-lives) C. 48 to 60 hours (4 to 5 half-lives) D. 120 hours (10 half-lives)
CORRECT ANSWER: C. Rationale: Under first-order kinetics, any drug reaches steady-state equilibrium in 4 to 5 half-lives (4
× 12h = 48h to 5 × 12h = 60h), regardless of the maintenance dose size. A loading dose achieves target concentration
immediately when t1/2 is long (e.g., Amiodarone, Digoxin, Azithromycin).
11. Which pharmacodynamic parameter defines the maximal physiological effect a drug can produce regardless
of how high the dose is increased, and is more clinically important than potency when selecting an analgesic or
diuretic?
A. Therapeutic Index (TD50/ED50) B. Efficacy (Emax) C. Potency (EC50) D. Bioavailability (F)
CORRECT ANSWER: B. Rationale: Efficacy (Emax) represents the maximum biological response achievable (height of the
dose-response curve), whereas Potency (EC50) merely dictates the dose required to produce 50% of that effect. Loop
diuretics have much higher efficacy than thiazides even if a specific thiazide is more potent per milligram.
NR 565 Advanced Pharmacology Final & Midterm Exam Test Bank (2026/2027) Page 2 of 14
HESI
NR 565 ADVANCED PHARMACOLOGY
FINAL & MIDTERM EXAM TEST BANK
100 Verified Exam Questions with Correct Answers & Detailed Clinical Rationales
✓ 100% VERIFIED CORRECT ANSWERS ✓ COMPLETE STEP-BY-STEP RATIONALES
✓ ALREADY GRADED A+ (GUARANTEED PASS)
SECTION 1: PHARMACOKINETICS, PHARMACODYNAMICS, PGX & QUESTIONS 1 – 5
PRESCRIPTIVE AUTHORITY OF 100
1. A nurse practitioner is prescribing Warfarin to a patient who was recently started on Fluconazole for
candidiasis. Which pharmacokinetic interaction is expected, and what adjustment is required?
A. Fluconazole induces CYP2C9, decreasing Warfarin levels and requiring a dose increase.
B. Fluconazole inhibits CYP2C9, increasing S-warfarin levels and bleeding risk; reduce Warfarin dose and monitor INR.
C. Fluconazole blocks intestinal P-glycoprotein efflux, preventing Warfarin absorption.
D. Fluconazole competes for renal tubular secretion, prolonging prothrombin time.
CORRECT ANSWER: B. Rationale: S-warfarin (the more potent enantiomer) is metabolized primarily by hepatic CYP2C9.
Fluconazole, Amiodarone, and Trimethoprim-Sulfamethoxazole are potent CYP2C9 inhibitors that significantly elevate INR and
bleeding risk.
2. Prior to initiating Carbamazepine in a patient of Southeast Asian descent for trigeminal neuralgia, FDA
guidelines mandate pharmacogenomic screening for which allele to prevent Stevens-Johnson Syndrome (SJS)
and Toxic Epidermal Necrolysis (TEN)?
A. HLA-B*5701 B. CYP2C19*2 C. HLA-B*1502 D. TPMT*3A
CORRECT ANSWER: C. Rationale: The HLA-B*1502 allele strongly predisposes patients of Asian ancestry to fatal
Carbamazepine- and Phenytoin-induced SJS/TEN. (HLA-B*5701 screens for Abacavir hypersensitivity; TPMT screens for
Azathioprine myelosuppression).
3. A postoperative patient receives oral Codeine for pain control but reports zero analgesic relief despite full
adherence. Genetic testing reveals the patient is a CYP2D6 ultrarapid or poor metabolizer. Which finding explains
a lack of analgesia?
A. Poor CYP2D6 metabolizers cannot O-demethylate Codeine into its active metabolite, Morphine.
B. Ultrarapid CYP2D6 metabolizers clear Codeine via renal filtration before receptor binding.
C. Codeine requires CYP3A4 activation into hydromorphone.
D. Poor CYP2D6 metabolizers experience rapid mu-opioid receptor desensitization.
CORRECT ANSWER: A. Rationale: Codeine is an inactive prodrug that requires hepatic CYP2D6 conversion into Morphine
for analgesia. Poor metabolizers get zero pain relief, whereas ultrarapid metabolizers generate toxic morphine levels
(contraindicated in children and breastfeeding mothers).
4. Under DEA federal controlled substance regulations, which prescribing rule applies to Schedule II controlled
substances (e.g., Oxycodone, Methylphenidate, Fentanyl)?
A. Up to 5 refills are permitted within a 6-month window.
B. No refills are permitted; a new prescription is required for each dispensing, though multiple dated sequential prescriptions up
to a 90-day supply may be issued.
C. Schedule II prescriptions may be telephoned to the pharmacy for routine maintenance.
D. Nurse practitioners are federally prohibited from prescribing Schedule II drugs in all 50 states.
CORRECT ANSWER: B. Rationale: Schedule II drugs have high abuse potential and zero refills allowed. Providers may
issue up to three sequential 30-day prescriptions with explicit "Do not fill until [Date]" instructions if allowed by state law.
5. An elderly patient presents with hypoalbuminemia (serum albumin 2.1 g/dL) due to malnutrition and takes
Phenytoin (90% protein-bound). Why is a standard total serum Phenytoin level misleading in this patient?
NR 565 Advanced Pharmacology Final & Midterm Exam Test Bank (2026/2027) Page 1 of 14
, SECTION 1 (CONT.): PHARMACODYNAMICS, BEERS CRITERIA & SPECIAL QUESTIONS 6 – 13 OF
POPULATIONS 100
6. A patient who is physically dependent on high-dose full mu-opioid agonists (Heroin/Fentanyl) is inadvertently
given Buprenorphine while full opioids still occupy their receptors. Within 15 minutes, the patient develops severe
abdominal cramps, diaphoresis, and agitation. What pharmacodynamic property of Buprenorphine explains this?
A. Pure competitive mu-opioid antagonism with low receptor affinity.
B. Partial mu-opioid agonist with very high receptor affinity, displacing full agonists and precipitating acute withdrawal.
C. Inverse agonism at GABA-A chloride channels.
D. Non-competitive blockade of N-methyl-D-aspartate (NMDA) receptors.
CORRECT ANSWER: B. Rationale: Buprenorphine is a partial mu-opioid agonist with extremely high binding affinity.
Administering it before a patient is in mild-to-moderate withdrawal displaces full agonists and drops intrinsic receptor
activation, causing precipitated withdrawal.
7. A 54-year-old patient taking Simvastatin 40 mg daily begins drinking 16 oz of grapefruit juice every morning.
Two weeks later, the patient presents with severe diffuse myalgias and dark brown urine. What is the mechanism?
A. Grapefruit furanocoumarins inhibit intestinal CYP3A4, drastically reducing first-pass metabolism and causing statin-induced
rhabdomyolysis.
B. Grapefruit juice induces hepatic CYP2C9, generating myotoxic statin metabolites.
C. Vitamin C acidifies the urine and precipitates Simvastatin crystals in the renal tubules.
D. Grapefruit juice blocks hepatic OATP1B1 uptake, lowering plasma statin concentrations.
CORRECT ANSWER: A. Rationale: Simvastatin, Lovastatin, and Atorvastatin undergo extensive intestinal and hepatic
CYP3A4 metabolism. Grapefruit juice irreversibly inhibits intestinal CYP3A4, increasing systemic statin exposure up to 10-fold
and triggering rhabdomyolysis. (Pravastatin and Rosuvastatin are non-CYP3A4 alternatives).
8. According to the American Geriatrics Society (AGS) Beers Criteria, why are first-generation antihistamines
(Diphenhydramine) and tricyclic antidepressants (Amitriptyline) strongly avoided in older adults?
A. They induce severe hyperkalemia and Type 4 renal tubular acidosis.
B. Their potent antimuscarinic (anticholinergic) activity precipitates acute delirium, falls, cognitive decline, blurred vision, and
urinary retention.
C. They cause irreversible pulmonary fibrosis within 30 days.
D. They selectively stimulate beta-1 adrenergic receptors.
CORRECT ANSWER: B. Rationale: Older adults have reduced central cholinergic reserve. Strong anticholinergic drugs cross
the blood-brain barrier and block M1–M3 receptors, significantly increasing the risk of delirium, incident dementia, falls,
xerostomia, constipation, and acute urinary retention in BPH.
9. A 28-year-old pregnant woman at 10 weeks gestation presents with newly diagnosed hypertension (BP 158/98
mmHg). Which antihypertensive medication is strictly contraindicated due to fetal renal dysplasia,
oligohydramnios, and Potter sequence?
A. Labetalol B. Extended-release Nifedipine C. Lisinopril D. Alpha-Methyldopa
CORRECT ANSWER: C. Rationale: ACE inhibitors (Lisinopril), ARBs (Losartan), and Direct Renin Inhibitors (Aliskiren) are
teratogenic and carry an FDA Black Box Warning in pregnancy. Safe antihypertensives in pregnancy are Labetalol, Nifedipine,
Methyldopa, and Hydralazine.
10. A drug has an elimination half-life (t1/2) of 12 hours and is administered at a fixed maintenance dose every 12
hours without a loading dose. Approximately how long will it take to reach steady-state plasma concentration (94–
97%)?
A. 12 hours (1 half-life) B. 24 hours (2 half-lives) C. 48 to 60 hours (4 to 5 half-lives) D. 120 hours (10 half-lives)
CORRECT ANSWER: C. Rationale: Under first-order kinetics, any drug reaches steady-state equilibrium in 4 to 5 half-lives (4
× 12h = 48h to 5 × 12h = 60h), regardless of the maintenance dose size. A loading dose achieves target concentration
immediately when t1/2 is long (e.g., Amiodarone, Digoxin, Azithromycin).
11. Which pharmacodynamic parameter defines the maximal physiological effect a drug can produce regardless
of how high the dose is increased, and is more clinically important than potency when selecting an analgesic or
diuretic?
A. Therapeutic Index (TD50/ED50) B. Efficacy (Emax) C. Potency (EC50) D. Bioavailability (F)
CORRECT ANSWER: B. Rationale: Efficacy (Emax) represents the maximum biological response achievable (height of the
dose-response curve), whereas Potency (EC50) merely dictates the dose required to produce 50% of that effect. Loop
diuretics have much higher efficacy than thiazides even if a specific thiazide is more potent per milligram.
NR 565 Advanced Pharmacology Final & Midterm Exam Test Bank (2026/2027) Page 2 of 14
